C07K14/8107 - CPC Classification Index

ClassID:

97082 ⎘

C07K14/8107 - CPC Classification

Classification description:

Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof; Protease inhibitors Endopeptidase (E.C. 3.4.21-99) inhibitors

Sub-classes:

C07K14/811 » {Serine protease (E.C. 3.4.21) inhibitors} 260
C07K14/8139 » {Cysteine protease (E.C. 3.4.22) inhibitors, e.g. cystatin} 79
C07K14/8142 » {Aspartate protease (E.C. 3.4.23) inhibitors, e.g. HIV protease inhibitors} 6
C07K14/8146 » {Metalloprotease (E.C. 3.4.24) inhibitors, e.g. tissue inhibitor of metallo proteinase, TIMP} 74

Recent Application in this class:

20250235516

2025-07-24

PROTEIN-BASED ADVANCED WOUND HEALING SYSTEM

20250205319

2025-06-26

SYSTEMS, COMPOSITIONS, AND METHODS FOR TRANSPLANTATION

20210268078

2021-09-02

SYSTEMS, COMPOSITIONS, AND METHODS FOR TRANSPLANTATION

20210095004

2021-04-01

Modulators of Cas9 polypeptide activity and methods of use thereof

20200054768

2020-02-20

Factor IX encoding nucleotides

20200054767

2020-02-20

Factor IX encoding nucleotides

20190290741

2019-09-26

Systems, compositions, and methods for transplantation

20190046617

2019-02-14

Systems, compositions, and methods for transplantation

20180282368

2018-10-04

Method for separating and purifying α2-macroglobulin from Cohn Fraction IV precipitation

#10

20180134751

2018-05-17

Peptide and its derivatives capable of inhibiting replication of hepatitis V virus in human adipose-derived stem cells and hepatocytes

#11

20150174221

2015-06-25

Systems, compositions, and methods for transplantation

#12

20150079194

2015-03-19

Systems, compositions, and methods for transplantation and treating conditions

#13

20140178353

2014-06-26

Bacterial anti-phage defense systems

#14

20120189602

2012-07-26

Treatment and prevention of pulmonary conditions

#15

20110212105

2011-09-01

Method to block the infection by flaviviruses, molecules and uses

#16

20090247456

2009-10-01

Complexes of alpha (2) macroglobulin and antigenic molecules for immunotherapy

#17

20090093066

2009-04-09

Glycated peptides and methods of use

#18

20090068736

2009-03-12

Mutant proline-and-arginine rich peptides and methods for using the same

#19

20080188004

2008-08-07

ASSAY FOR DIABETES

#20

20080108547

2008-05-08

Protease Inhibitor

#21

20070172848

2007-07-26

Calpastatin (CAST) alleles

#22

20070128600

2007-06-07

Alpha macroglobulin family member

#23

20070105149

2007-05-10

Assay for diabetes

#24

20070021588

2007-01-25

Alpha macroglobulin protein family members

#25

20070009955

2007-01-11

Secreted polypeptide species associated with cardiovascular disorders

#26

20060287506

2006-12-21

Method for separating and concentrating biological materials using continuous-flow ultracentrifugation

#27

20060216807

2006-09-28

Membrane for removing proteases from liquids

#28

20050260726

2005-11-24

Novel human protease inhibitor and polynucleotides encoding the same

#29

20050245431

2005-11-03

Membrane, device and method for removing proteases from liquids

#30

20050202422

2005-09-15

Novel nucleic acids and polypeptides

#31

20050196754

2005-09-08

Novel nucleic acids and polypeptides

#32

20050170374

2005-08-04

Novel nucleic acids and polypeptides

#33

20050070477

2005-03-31

Compositions for treatment and prevention of pulmonary conditions

#34

20050059816

2005-03-17

Novel human protease inhibitor proteins and polynucleotides encoding the same

#35

20050037432

2005-02-17

Novel biomarkers of aggrecanase activity